For many conditions including immune-related ones, genetics often explains only a small fraction of the differences between ...
Biogen Inc. (Nasdaq: BIIB) and Vanqua Bio today announced a license agreement granting Biogen exclusive worldwide rights to Vanqua’s preclinical, oral C5aR1 antagonist. This agreement strengthens ...
LONDON, Oct 13 (Reuters) - British finance minister Rachel Reeves should use her budget in November to carry out a long overdue reform of the taxation system which could help her to raise more revenue ...
CTx001 is an investigational AAV-based gene therapy designed to modulate multiple pathways of the complement system Opti-GAIN is a first-in-human trial to evaluate the safety, tolerability, and ...
Opti-GAIN is a first-in-human trial to evaluate the safety, tolerability, and preliminary efficacy of CTx001 as a potential one-time treatment for GA Opti-GAIN builds on insights from i-GAIN, a ...
Having closed a nine-figure fundraising round, a newly launched biotechnology company hopes to rewire the immune system with drugs aimed at a special kind of nerve cell. Nilo Therapeutics debuted ...
Scientists have discovered that DMT, a natural compound found in plants and even the human brain, can dramatically reduce brain damage caused by stroke. The psychoactive molecule, long known for its ...
The ram air turbine, used when electrical power or hydraulic pressure fails, was deployed during an Air India flight that landed safely over the weekend. The same system had been activated during a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback